Condensed-cyclic compound and organic light-emitting device comprising the same

US10121974B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10121974-B2
Application numberUS-201514743217-A
CountryUS
Kind codeB2
Filing dateJun 18, 2015
Priority dateDec 31, 2014
Publication dateNov 6, 2018
Grant dateNov 6, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A condensed-cyclic compound is represented by Formula 1: where X, L 1 to L 3 , R 1 to R 3 , Ar 1 to Ar 6 , c1 to c3, a1 to a2, and b1 to b3 are as defined in the specification.

First claim

Opening claim text (preview).

What is claimed is: 1. A condensed-cyclic compound represented by one of Formula 1, 1B, and 1C: wherein, in Formula 1, X is selected from O, S, and N(R 11 ); when X is O, A is selected from a naphthalene, an anthracene, a phenanthrene, a chrysene, and a pyrene, and ii) when X is S or N(R 11 ), A is selected from a benzene, a naphthalene, an anthracene, a phenanthrene, a chrysene, and a pyrene; in Formulae 1B and 1C, X is selected from O, S, N(R 11 ), Si(R 12 )(R 13 ) and C(R 15 )(R 16 ); in Formula 1, 1B, and 1C L 1 to L 3 are each independently selected from: a phenylene group, and a phenylene group substituted with at least one selected from a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid or a salt thereof, a sulfonic acid or a salt thereof, a phosphoric acid or a salt thereof, a C 1 -C 20 alkyl group, a C 1 -C 20 alkoxy group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclopentenyl group, a cyclohexenyl group, a phenyl group a1 to a3 are each independently selected from 0 and 1; Ar 1 to Ar 6 are each independently selected from a group represented by one of Formulae 6-1 to 6-28: wherein, in Formulae 6-1 to 6-28, * indicates a binding site to an adjacent atom; c1 to c3 are each independently selected from 0 and 1, provided that a sum of c1, c2, and c3 is 1 or more; R 1 to R 3 are each independently selected from a hydrogen, a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid or a salt thereof, a sulfonic acid or a salt thereof, a phosphoric acid or a salt thereof, a methyl group and a phenyl group b1 to b3 are each independently an integer selected from 0 to 3; R 11 , R 12 , R 13 , R 15 , and R 16 are each independently selected from a methyl group and a phenyl group; and B is a boron atom. 2. The condensed-cyclic compound as claimed in claim 1 , wherein L 1 to L 3 are each independently selected from a group represented by one of Formulae 3-1 to 3-3: wherein, in Formulae 3-1 to 3-3, Z 1 is selected from a hydrogen, a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid or a salt thereof, a sulfonic acid or a salt thereof, a phosphoric acid or a salt thereof, a C 1 -C 20 alkyl group, a C 1 -C 20 alkoxy group, and a phenyl group d1 is an integer selected from 1 to 4; and * and *′ each indicate a binding site to an adjacent atom. 3. The condensed-cyclic compound as claimed in claim 1 , wherein L 1 to L 3 are each independently selected from a group represented by one of Formulae 4-1, 4-3, 4-8, 4-10, 4-17, 4-24, 4-26, and 4-28: wherein, in Formulae 4-1, 4-3, 4-8, 4-10, 4-17, 4-24, 4-26, and 4-28, *and *′ each indicate a binding site to an adjacent atom. 4. The condensed-cyclic compound as claimed in claim 1 , wherein a sum of c1, c2, and c3 is selected from 1 and 2. 5. The condensed-cyclic compound as claimed in claim 1 , wherein the condensed-cyclic compound is represented by one of Formulae 1A to 1C: wherein, in Formulae 1A, X is selected from S and N(R 11 ), in Formulae 1B and 1C, X is selected from O, S, N(R 11 ), Si(R 12 )(R 13 ), and C(R 15 )(R 16 ), and L 1 to L 3 , a1 to a3, Ar 1 to Ar 6 , c1 to c3, R 1 to R 3 , b1 to b3 and R 11 , R 12 , R 13 , R 15 , and R 16 are the same as defined in claim 1 . 6. The condensed-cyclic compound as claimed in claim 1 , wherein the condensed-cyclic compound is represented by one of Formulae 1-1 to 1-3 and Formulae 2-1 to 2-3: wherein, in Formulae 1-1 and 2-1, X is selected from S and N(R 11 ), in Formulae 1-2, 1-3, 2-2 and 2-3, X is selected from O, S, N(R 11 ), Si(R 12 )(R 13 ), and C(R 15 )(R 16 ), and in Formulae 1-1 to 1-3 and Formulae 2-1 to 2-3, L 1 , L 2 , a1, a2, Ar 1 to Ar 4 , R 1 to R 3 , b1 to b3, R 11 , R 12 , R 13 , R 15 , and R 16 are the same as defined in claim 1 . 7. The condensed-cyclic compound as claimed in claim 1 , wherein the condensed-cyclic compound is represented by one selected from Formulae 1-1(1) to 1-3(1) and Formulae 2-1(1) to 2-3(1): wherein, in Formulae 1-1(1) and 2-1(1), X is selected from S and N(R 11 ), in Formulae 1-2(1), 1-3(1), 2-2(1) and 2-3(1), X is selected from O, S, N(R 11 ), Si(R 12 )(R 13 ), and C(R 15 )(R 16 ), in Formulae 1-1(1) to 1-3(1) and Formulae 2-1(1) to 2-3(1), L 1 , L 2 , a1, a2, Ar 1 to Ar 4 and R 11 , R 12 , R 13 , R 15 , and R 16 are the same as defined in claim 1 , and R 1a to R 1f , R 2a to R 2c , and R 3a to R 3c are the same as defined in connection with R 1 as described in claim 1 . 8. The condensed-cyclic compound as claimed in claim 7 , wherein Ar 1 to Ar 4 are each independently selected from Formulae 6-1 to 6-28, and R 1a to R 1f , R 2a to R 2c , and R 3a to R 3c are each independently selected from a hydrogen, a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid or a salt thereof, a sulfonic acid or a salt thereof, a phosphoric acid or a salt thereof, a methyl group, and a group represented by Formula 6-1: wherein, in Formulae 6-1 to 6-28, * indicates a binding site to an adjacent atom. 9. The condensed-cyclic compound as claimed in claim 1 , wherein the condensed-cyclic compound is represented by one of Compounds 14 to 26, 40 to 169 and 182 to 231:

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10121974B2 cover?
A condensed-cyclic compound is represented by Formula 1: where X, L 1 to L 3 , R 1 to R 3 , Ar 1 to Ar 6 , c1 to c3, a1 to a2, and b1 to b3 are as defined in the specification.
Who is the assignee on this patent?
Samsung Display Co Ltd
What technology area does this patent fall under?
Primary CPC classification C07F5/027. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).